⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HROW News
Harrow, Inc. Common Stock
Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030
globenewswire.com
HROW
Form 8-K
sec.gov
HROW
Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth
globenewswire.com
HROW
Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting
globenewswire.com
HROW
Form 8-K
sec.gov
HROW
Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference
globenewswire.com
HROW
Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication
globenewswire.com
HROW
Form 8-K
sec.gov
HROW
Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance
globenewswire.com
HROW
Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026
globenewswire.com
HROW